With regard to recognition, certificate and scope of application issued to GBA Medical Device Services GmbH is already available.

In the routine analysis of molds in interiors, the genus Trichoderma plays a role in the evaluation, but because these are typical molds on rotting wood or fruit, their detection plays a rather subordinate role in the evaluation of interior damage. According to TRBA 460, the mold species Trichoderma viride is classified in biological risk group 1. Thus, there is no known increased risk of infection for humans.

GBA Group's new laboratory and logistics site in Westborough (MA) will support growing demand from international clients.

Located in the greater Boston area, a pharmaceutical and biotech hub, the laboratory and logistics site will be fully operational in October 2023 and will offer a broad range of services in the areas of central lab and clinical trial supply.

ICCR’s study director Dr Christina Spohr and her team participated in a project to investigate in vitro skin and eye irritation test methods applied to live bacterial test items. The results were recently published in Regulatory Toxicology and Pharmacology and show that proper selection of available OECD test methods and relevant modifications of the test protocols can provide for valid in vitro studies of live microorganisms. In particular, the project addressed interference of the live lactic acid bacteria and their formulations with test method indicators and handling protocols.

The FDA recently published an "Immediately in Effect Guidance for Industry" for testing diethylene glycol (DEG) and ethylene glycol (EG). According to FDA “this guidance is intended to alert pharmaceutical manufacturers, compounders, repackers, and suppliers to the potential public health hazard of glycerin and other high-risk drug components contaminated with DEG or EG”.

Examples of high-risk drug components under the following Link: